Breaking News

Symbiosis Completes UK Research and Innovation Project

Will enhance the manufacturing supply chain for ATMPs within the UK.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Symbiosis Pharmaceutical Services, a contract manufacturing organization (CMO) specializing in sterile global manufacture of pharmaceuticals, vaccines and biopharmaceuticals including Advanced Therapeutical Medicinal Products (ATMPs), has completed a £1.3 million collaborative UK Research and Innovation Project (UKRI)-funded project as part of the medicines manufacturing challenge.   Symbiosis and The Cell and Gene Therapy Catapult (CGT Catapult) have successfully developed and demonstrated a ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters